Predicting early post transplant sepsis and first 30 days mortality after LDLT using pre transplant Serum procalcitoni
Not Applicable
- Conditions
- Health Condition 1: K746- Other and unspecified cirrhosis ofliver
- Registration Number
- CTRI/2021/03/032213
- Lead Sponsor
- ILBS Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adult patients (18-65 years) undergoing live donor liver transplant in Institute of Liver and Biliary Sciences
Exclusion Criteria
Paediatric patients ( <18 years)
Non consenting patient
Acute liver failure
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Correlation of pre transplant serum procalcitonin with development of early post transplant sepsis (within 7 days)Timepoint: 7 days
- Secondary Outcome Measures
Name Time Method Pretransplant and surgical risk factors associated with post transplant <br/ ><br>sepsis <br/ ><br> <br/ ><br>Correlation of pre transplant serum procalcitonin with first 30 days <br/ ><br>mortalityTimepoint: 30 days